Skip to main content

Peer Review reports

From: Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial

Original Submission
16 May 2023 Submitted Original manuscript
25 May 2023 Reviewed Reviewer Report
4 Jun 2023 Reviewed Reviewer Report - Jieqiong Liu
10 Jun 2023 Reviewed Reviewer Report
3 Jul 2023 Author responded Author comments - Jun Cao
Resubmission - Version 2
3 Jul 2023 Submitted Manuscript version 2
3 Jul 2023 Reviewed Reviewer Report
10 Jul 2023 Reviewed Reviewer Report - Jieqiong Liu
17 Jul 2023 Reviewed Reviewer Report
20 Jul 2023 Author responded Author comments - Jun Cao
Resubmission - Version 3
20 Jul 2023 Submitted Manuscript version 3
Publishing
23 Jul 2023 Editorially accepted
9 Aug 2023 Article published 10.1186/s12916-023-02999-0

You can find further information about peer review here.

Back to article page